Resources

Proteomics Databases



Metabolomics Databases

• • Why Are Low-Abundance Lysosomal Proteins Hard to Detect?

  A problem-solving guide explaining why low-abundance lysosomal proteins are hard to detect in bulk samples and how lysosome enrichment proteomics can improve detection chance without guaranteeing recovery.

• • Lysosome Isolation for Proteomics: When Is Enrichment Needed?

  A selection guide explaining when lysosome isolation and proteomics or lysosome enrichment proteomics is needed, and how to choose between laboratory isolation and customer-enriched fractions.

• • Sample Requirements for Lysosomal Proteomics Analysis

  A submission guide to lysosomal proteomics sample requirements covering accepted sample types, starting amounts, storage, buffers, and required documentation.

• • What Is Lysosomal Proteomics Analysis and When Is It Useful?

  A technical awareness guide to lysosomal proteomics analysis covering what the method measures, when it is useful, and how it differs from bulk proteomics.

• • Integrated EV Isolation-to-Proteomics Service for Source Material-Based Exosome Studies

  MtoZ Biolabs evaluates plasma, serum, urine, CSF, and cell culture-conditioned medium projects and supports EV isolation, enrichment or purification, applicable EV characterization, LC-MS/MS protein identification or quantitative proteomics, and corresponding data analysis according to the approved project scope.

• • What Information Is Required to Evaluate a Metabolomics or Lipidomics Project?

  MtoZ Biolabs evaluates metabolite- and lipid-focused projects using the research objective, sample matrix and condition, group structure, preparation history, target information, and expected quantification or annotation outcome.

• • Exosome Proteomics Analysis Service for EV Protein Profiling and Comparative Research

  MtoZ Biolabs supports project evaluation from source samples, pre-isolated EVs, EV protein lysates, or prepared peptides for LC-MS/MS protein identification, quantitative profiling, differential analysis, and project-specific candidate prioritization.

• • Untargeted Metabolomics and Lipidomics Services: From Broad Profiling to Candidate Annotation

  MtoZ Biolabs evaluates untargeted metabolomics and untargeted lipidomics projects based on the research objective, sample matrix, group design, preparation history, and expected result, with candidate annotation interpreted according to the available database and spectral evidence.

• • Exosome Proteomics Sample Preparation Service: Support for Biofluids, Cell Culture-Conditioned Medium, and Isolated EVs

  MtoZ Biolabs evaluates plasma, serum, urine, CSF, cell culture-conditioned medium, pre-isolated EVs, EV protein lysates, and prepared peptides to determine whether EV separation, additional purification, protein preparation, or direct LC-MS/MS analysis is appropriate for the proposed study. 

• • Metabolomics and Lipidomics Study Design: Matching Analysis Strategies to Research Questions

  MtoZ Biolabs evaluates projects involving broad profiling, predefined targets, or exosome lipid analysis based on the research objective, sample matrix, group design, preparation history, target information, and expected result.